ASRT ASRT

Assertio Stock Price

3.20
0.07 (2.24%)
Upgrade to Real-Time
Regular Market
3.20
Volume 148,575
Bid Price 3.19
Ask Price 3.20
News -
Day High 3.21

Low
0.8512

52 Week Range

High
3.519

Day Low 3.075
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Assertio Holdings Inc ASRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.07 2.24% 3.20 10:03:33
Open Price Low Price High Price Close Price Prev Close
3.15 3.075 3.21 3.13
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
746 148,575 $ 3.16 $ 469,125 - 0.8512 - 3.519
Last Trade Time Type Quantity Stock Price Currency
10:04:16 1 $ 3.19 USD

Period:

Draw Mode:

Assertio Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 145.39M 45.43M 44.81M $ 111.01M $ 2.98M -0.01 41.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -151.29k 17.10%

more financials information »

Assertio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ASRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.763.21772.662.911,083,1940.4415.94%
1 Month2.373.21771.862.42920,2660.8335.02%
3 Months2.293.5191.862.67937,7860.9139.74%
6 Months1.323.5191.19012.41976,9791.88142.42%
1 Year1.553.5190.85121.90993,7411.65106.45%
3 Years3.4210.050.331.022,881,655-0.22-6.43%
5 Years7.3010.050.331.252,457,858-4.10-56.16%

Assertio Description

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Your Recent History
NASDAQ
ASRT
Assertio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220520 14:19:16